Sutherland Health Group raises £100,000

                                                                                                                              16 May 2013


                                                               SUTHERLAND HEALTH GROUP PLC
                                                   ("Sutherland Health Group" or "the Company")
                                                                          ISDX Symbol: SHGP


                                                          £100,000 Fundraise

The Board of Sutherland Health Group, a national supplier of patient hygiene, sexual health and gynaecology products to customers including the National Health Service ("NHS"), is pleased to announce, further to the announcement made on 18 March 2013, that subscribers have been procured for a total of 8,000,000 new Ordinary Shares, to be issued at a price of 1.25p per share. The gross proceeds of the funds raised are £100,000.

As part of the fund raising George Sutherland, Chief Executive, subscribed for 300,000 shares in the placing and is now beneficially interested in 28,371,220 Ordinary Shares representing 36.49 per cent. of the enlarged issued share capital. Application has been made for the new Ordinary Shares to be admitted to trading on the ISDX Growth Market, and it is expected that trading in the new Ordinary Shares will commence on 17 May 2013.

The total number of shares in issue will be 77,752,345

Shareholders who have in excess of 3% of the enlarged issued share capital are:-

Shareholder No of Shares % of issued share capital
George Sutherland* 25,018,800 32.18%
Athol Gold & Value 4,000,000 5.14%
Rhys Summerton 4,000,000 5.14%
Sutherland RBS** 3,352,420 4.31%
Suzanne Sutherland 3,044,540 3.91%
Roy Nominees 3,000,000 3.85%

Notes: * Includes 45,000 shares owned by his wife and fellow Director Sheena Sukumaran
          ** Sutherland RBS is a Pension Fund for the benefit of Chief Executive George Sutherland

The proceeds of the fundraise will be used by the Company for working capital purposes and to accelerate its sales, marketing and business development activities. In addition to a planned increase in distribution of its current product range, there is a new product development programme underway and the Company is currently actively exploring opportunities to work closely with complementary organisations. The Company may also seek out compatible acquisition opportunities when appropriate.

The Directors of the Issuer accept responsibility for this announcement.

For further information:

John French, Chairman
Sutherland Health Group plc
T: 07836 722 482

Ross Andrews
Andrew Jones
Zeus Capital Ltd
T: 0161 831 1512

Notes to Editors:

Sutherland Health Group Plc is a national supplier of patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals who also work within the health sector.

The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands: Condomania® Condoms; Sutherland® Patient Hygiene and Personal Care; Lubricating Jelly; and Vision® pregnancy and gynaecology diagnostics. These products have already become established within the NHS business.

The Group is ISO and MHRA registered, and at present principally manufactures and operates within the United Kingdom.

For further information on the Company visit

Latest news RSS


Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017


Final Results 30th September 2016

Sutherland Health Group Final Results September 2016


Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up


For further information, please read our Privacy Policy.